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Male sex determination is mediated sequentially by
sex-determining region Y (SRY) and related SRY-
box 9 (SOX9) transcription factors. To understand
the gene regulatory hierarchy for SRY and SOX9, a
series of chromatin immunoprecipitation and whole-
genome promoter tiling microarray (ChIP-Chip) ex-
periments were conducted with mouse gonadal cells
at the time of sex determination. SRY and SOX9 bind
to the promoters of many common targets involved
in testis differentiation and regulate their expression
in Sertoli cells. SRY binds to various ovarian differen-
tiation genes and represses their activation through
WNT/b-catenin signaling. Sertoli cell-Sertoli cell
junction signaling, important for testis cord forma-
tion, is the top canonical pathway among the SRY
and SOX9 targets. Hence, SRY determines Sertoli
cell fate by repressing ovarian and activating testic-
ular differentiation genes, promotes early Sertoli
cells to form testis cord, and then passes on its func-
tions to SOX9, which regulates common targets and
activates its own gene regulatory program, beyond
SRY actions, in sex determination.
INTRODUCTION
The Y chromosome plays a pivotal role in mammalian sex deter-
mination. The discovery of the sex-determining region Y (Sry)
gene as the sex-determining gene on this chromosome marks
the most significant development in the field (Gubbay et al.,
1990; Sinclair et al., 1990). SRY is postulated to determine
the fate of the supporting cells into the Sertoli cell lineage, the
foremost event of the developmental cascade (McLaren,
1991). The Sertoli cells, in turn, bring about a variety of cellular
and developmental events, including pre-Sertoli cell prolifera-
tion, recruitment of additional supporting cells into Sertoli cells,
blockage of meiosis in germ cells, and the formation of testis
cords, the first visible structure of the embryonic testis. Recentstudies suggest that SRY synergizes with steroidogenic factor
1 (SF1, also known as nuclear receptor subfamily 5, group A,
member 1 [NR5A1]) and binds to a 1.4 kb core domain of the
testis enhancer of Sox9 (TESCO), between 13 and 10 kb
upstream of the transcription start site of the related SRY-box
9 (Sox9) gene (Sekido and Lovell-Badge, 2008), and greatly
upregulates Sox9 expression. SOX9, in turn, interacts with SF1
and binds to the same or similar binding sites within TESCO,
propagates its own expression in a positive feedback loop,
and propels testis differentiation beyond SRY actions. Because
ectopic expression of Sox9, by either transgenic means or acti-
vating mutations (Bishop et al., 2000; Qin et al., 2004; Vidal et al.,
2001), results in male (M) sex differentiation without a functional
Sry, it has been argued that the primary role of Sry is to activate
Sox9 in this Y chromosome-initiated developmental process
(Sekido and Lovell-Badge, 2009).
Various studies, however, suggest that SRY might serve
diverse functions in not only activating Sox9 but also regulating
other important sex-determining genes, reprogramming the
chromatin landscape, and epigenetically establishing the sup-
porting cells to a Sertoli cell lineage (Oh and Lau, 2006). SRY
lacks a transcriptional domain present in most SOX proteins
and needs to recruit corepressors and coactivators to accom-
plish its transcriptional and/or epigenetic functions. Indeed,
numerous SRY interactive proteins with a variety of transcrip-
tional or chromatin modulating properties have been identified
with several molecular approaches (Lau and Li, 2009; Li
et al., 2006; Oh et al., 2005; Peng et al., 2009; Sekido and
Lovell-Badge, 2008; Wu et al., 2009). SRY forms transcription
complexes with either SF1 or SP1 and transactivates the
respective target genes (Sekido and Lovell-Badge, 2008; Wu
et al., 2009). SRY could interact with nuclear b-catenin and
repress WNT signaling-dependent gene expression (Lau and
Li, 2009). SRY also interacts with numerous transcription
factors (Wissmu¨ller et al., 2006) and modulates the respective
transcriptional activities. SRY binds the Kru¨ppel-associated
box-only (KRAB-O) protein and recruits a gene-silencing com-
plex, consisting of the KAP1-HP1 (KRAB-associated protein 1-
heterochromatin protein 1), to the promoters and represses the
target genes (Oh et al., 2005; Peng et al., 2009). SRY also inter-
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poly(ADP-ribosyl)ate nuclear proteins and modulate their affinity
to their respective target sequences (Li et al., 2006). Hence, SRY
could reprogram epigenetically the chromatin landscape of its
targets and permanently establish the Sertoli cell lineage in the
supporting cells of the developing testis. At present, the full
spectrum of SRY-containing transcription and chromatin remod-
eling complexes in the Sertoli precursors is still unknown. These
observations, however, raise some important questions. Is Sox9
the only target gene for SRY? If not, what are the other target
genes for the SRY-containing transcription complexes? Are
any of its targets involved in the cascade of cellular events in
testis differentiation? Furthermore, because SOX9 is responsible
for propagating testis differentiation beyond SRY actions and
their DNA binding high-mobility group boxes are functionally
interchangeable (Bergstrom et al., 2000), do SRY and SOX9
bind and regulate similar target genes in the samedevelopmental
pathway?
To address the above questions, we had conducted a series
of experiments using the chromatin immunoprecipitation (ChIP)
and whole-genome promoter tiling microarray (ChIP-Chip) strat-
egy on fetal gonads frommouse embryos at embryonic day 11.5
(E11.5) and E12.5 developmental stages to identify the target
genes for SRY and SOX9, respectively. Our results provided
some answers to these questions, suggesting that SRY-contain-
ing transcription complexes bind to the promoters of a large
number of target genes, including numerous known testis
and ovarian-differentiating genes. SRY and SOX9 share and
regulate a significant number of common targets, which serve
important functions in early events in testis differentiation,
including Sertoli cell fate determination, M germ cell definition,
and testis cord formation and differentiation.
RESULTS
SRY and SOX9 Recognize a Large Number of Common
Target Genes during Sex Determination
Using two specific antibodies against themouse SRY and SOX9,
respectively (Figure S1), gonadal cells from E11.5 embryos were
processed for SRY ChIP, at which time SRY expression was at
its peak, whereas M gonadal cells from E12.5 embryos were
used for SOX9 ChIP, at which time SRY expression was at its
minimum or had disappeared (Taketo et al., 2005). We surmise
that using highly specific antibodies and gonadal cells at distinct
embryonic stages had greatly enhanced the specificity of the
respective SRY or SOX9 bound chromatin in our ChIP-Chip
studies. The crude ChIP data were further analyzed with the
Mpeak program (Zheng et al., 2013), which identified statistically
significant binding peaks by scanning the hybridization signals
along parallel promoter tiling regions between two biologicalFigure 1. SRY and SOX9 ChIP-Chip Signals and Gene Differential Ex
Genome Browser
(A) Distributions of SRY (green) and SOX9 (blue) binding signals on mouse chromo
expressed genes between M and F supporting cells at E11.5, E12.5, and E13.5 g
and E13.5 versus E11.5 stages (pink). Examples of significant andminimal SRY an
in dark red and dark blue, respectively.
(B) Enlargement at chromosome band 2qA3, showing SRY and SOX9 signals am
(C) Signals at individual gene level, showing almost identical patterns for SRY anreplicates. Using an optimal threshold value of 1 for prefiltering
and p value <0.01, we had identified a total of 3,083 target genes
for SRY in E11.5 gonads and 1,903 target genes for SOX9 in
E12.5 M gonads, respectively (Tables S1 and S2). These two
transcriptional factors regulate a substantially large number
(907) of common genes, about one-third and half of the SRY
and SOX9 targets, respectively. These observations are signifi-
cant because the respective targets were identified with inde-
pendent and biologically replicated experiments with gonadal
cells at two distinct developmental stages, i.e., E11.5 for SRY
and E12.5 for SOX9, suggesting that SOX9 must have assumed
a sizable portion of the SRY regulatory program in the process.
A total of 126 and 84 target genes respectively for SRY
and SOX9 previously demonstrated to be associated with sex
determination, to possess high Mpeak (binding) scores, and/or
to be highly differentially expressed between M and female
(F) supporting cells, were selected for confirmation analysis
with gene-specific primer pairs (Table S3) and quantitative
PCR with corresponding immunoprecipitated chromatin DNAs.
Primers from the SRY and SOX9 binding sites at TESCO (Sekido
and Lovell-Badge, 2008) and the mouse cerebellum 4 precursor
(Cbln4) (Bradford et al., 2009) were used as positive controls.
This initial analysis showed 89.7% and 88.1% confirmation
for SRY and SOX9 binding to the respective target genes
(Figure S2).
SRY and SOX9 Bind Preferentially to the Same Regions
at the Promoters of Their Common Targets
To determine the overall distributions of SRY and SOX9 binding
signals in the entire mouse genome and to compare them to
those of differentially expressed genes, the expression levels
between M and F supporting cells at E11.5, E12.5, and E13.5
stages and between E12.5/E13.5 and E11.5 were calculated
from microarray expression data (Jameson et al., 2012) and
tabulated as log2 ratios at the transcription start site of each an-
notated gene and analyzed with the Genome Browser (Karolchik
et al., 2011). At the chromosome level, SRY andSOX9ChIP-Chip
signals were preferentially localized at chromosomal regions
containing differentially expressed genes (Figure 1A). At the
chromosomal subband level, SRY and SOX9 bindings could
be identified as differentially regulated genes in M supporting
cells or among the three developmental stages (Figure 1B). At
the specific gene level, the binding patterns of SRY and SOX9
were almost identical at the promoters of their common target
genes, e.g., prostaglandin D2 synthase (Ptgds) (Figure 1C).
These patterns of the SRY and SOX9 bindings were most prev-
alent among their common targets (Figure S3), suggesting that
they could bind to the same, if not identical, regions and regulate
their common target genes in similar manners.pression Patterns on Mouse Chromosome 2, as Visualized by the
some 2 as visualized with the Genome Browser, and compared to differentially
onads (jade), and between supporting cells of M gonads at E12.5 versus E11.5
d SOX9 bindings and differential gene expression in supporting cells are boxed
ong common targets.
d SOX9 signals on the Ptgds promoter.
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SRY and SOX9 Bind and Regulate the Promoter
Activities of Common and Unique Target Genes
in a Mouse Sertoli Cell Line
Among the SRY and SOX9 targets, there are numerous notable
ones, such as Ptgds (Wilhelm et al., 2007), desert hedgehog
(Dhh) (Clark et al., 2000; Yao et al., 2002), cytochrome P450,
family 26, subfamily B, polypeptide 1 (Cyp26b1) (Bowles et al.,
2006), fibroblast growth factor 9 (Fgf9) (Colvin et al., 2001), glial
cell line-derived neurotrophic factor (Gdnf) (Oatley and Brinster,
2008), and others previously demonstrated to serve vital func-
tions in sex determination and differentiation (Table S4). To eval-
uate the functional effects of SRY and SOX9 on the target genes,
promoters containing the specific SRY/SOX9 binding peaks
and transcription start sites were inserted immediately upstream
of a promoter-less luciferase reporter and analyzed with trans-
fection assays in a mouse Sertoli cell line, MSC1 (McGuinness
et al., 1994), with and without a mouse Sry or Sox9 transgene.
A luciferase reporter directed by the TESCO enhancer and a
minimal promoter (Sekido and Lovell-Badge, 2008) was used
as a positive control. Transfection ofMSC1 cells with this TESCO
reporter with either Sry or Sox9 resulted in moderate increases
in reporter activities, as compared to those with TESCO reporter
alone (Figure 2B). Significantly, inclusion of Sf1 (Nr5a1) expres-
sion vector in the transfections greatly stimulated the reporter
activities, which were further amplified with either Sry or Sox9
coexpression. These results corroborated with those from the
initial study on TESCO (Sekido and Lovell-Badge, 2008), thereby
supporting the validity of our promoter assay system.
Initially, 23 putative target genes (8 common, 10 SRY-unique,
and 5 SOX9-unique targets) were selected for detailed promoter
characterization in MSC1 cells (Tables S1 and S2 for remainders
of SRY and SOX9 targets). Most promoters of the selected target
genes were capable of responding to the transactivation effects
of a cotransfected Sry or Sox9 gene (Figure 2A). Interestingly,
several specific targets for SRY (e.g., Mmd2, Scube2, Fgf9,
and Gdnf) were capable of responding to SOX9 stimulation
and vice versa (e.g., Erbb3 and Ctgf) in this promoter assay sys-
tem. We surmise that the respective transcription factors, i.e.,
SRY or SOX9, were expressed at high levels in the transiently
transfected MSC1 cells, and their DNA binding domains are
functionally interchangeable (Bergstrom et al., 2000); they could
bind to the cis elements of each other’s target promoters,
thereby stimulating the luciferase reporter activities.
We further noted that the promoter from Adamts16 lacked
any response to a cotransfected Sox9 gene, and those from
Ube1y1 and Wnt5a showed minimal stimulation by either the
Sry or Sox9 expression. The Ptgds promoter-directed reporterFigure 2. Promoter Assays on Selected Target Genes of SRY and SOX
(A) Individual promoter assays on SRY and SOX9 targets in the Sertoli cell line, M
(B) SRY and SOX9 exacerbation of SF1 stimulation of a TESCO-directed lucifera
(C and D) Promoter assays showing SRY and SOX9 exacerbation of SF1 (C) and
(E) SRY ovarian target promoter-directed reporter assay in KK1 granulosa cell lin
SRY coexpression.
(F) Similar transfection assays, showing SOX9 repression of WNT/b-catenin acti
(G) Similar promoter-directed reporter assays, as in (A), among target genes in t
(H) Sf1 could exacerbate the transactivation of reporters directed by the promot
See Tables S1 and S2 for all SRY and SOX9 targets at E11.5 and E12.5 gon
experiments.showed only moderate stimulation by Sox9, but not Sry, as re-
ported by Wilhelm et al. (2007). Currently, the molecular mecha-
nism(s) for such unresponsiveness of the respective promoters
in this assay system is unknown. Conceivably, yet-to-be defined
critical cofactors for SRY or SOX9 for their regulatory activities
on the respective promoters were absent or insufficient in the
MSC1 cells. Because SF1 has been demonstrated to work
collaboratively with SRY in transcriptional regulation of their
responsive genes, i.e., Sox9 (Sekido and Lovell-Badge, 2008),
we had selected a few target promoter-luciferase constructs
for further analysis. Inclusion of Sf1 in the Sry transfection greatly
exacerbated the activities of the reporter in the promoter assays
(Figure 2C). Because SOX9 could also interact with SF1 and
regulate its own gene transcription in a positive feedback loop,
we had performed parallel Sox9 transfection assays similarly
as those for Sry and Sf1. Our results demonstrated that indeed
SOX9 could synergistically interact with SF1 and transactivate
the same reporters directed by the respective SRY or common
target promoters, similar to SRY (Figure 2C).
Interestingly, as a SRY interactive protein, cotransfection of
PARP1 with Sry could stimulate the Ptgds promoter-directed
luciferase activities to about 3-fold in MSC1 cells, as compared
to control, and those with Sry or PARP1 alone (Figure 2D). Such
SRY-PARP1 stimulation of Ptgds promoter was at a similar level
as that by SOX9 (Figure 2A). These results support our postula-
tion of a likely requirement(s) of cofactors for SRY and/or SOX9
transactivation of their respective target genes.
SRY Represses Ovarian-Determining Genes
by Interfering with Their Activation
by WNT/b-catenin Signaling
As the M sex determinant, SRY not only activates the testicular
differentiation but also likely represses the ovarian-determining
program(s). Several key ovarian-differentiating genes, i.e., folli-
statin (Fst), Iroquois-related homeobox 3 (Irx3), bone morphoge-
netic protein 2 (Bmp2), and guanine nucleotide binding protein
(G protein), gamma 13 (Gng13), were SRY targets, but not
SOX9. Because b-catenin is the major mediator of the RSPO1-
WNT4 signaling responsible for activating the early events
of ovarian determination and differentiation (Maatouk et al.,
2008), we had evaluated the effects of SRY in b-catenin transac-
tivation of reporter genes directed by the respective promoters
of these ovarian-determining genes in a granulosa cell line,
KK1. Our results showed that b-catenin could indeed stimulate
the activities of three of four (i.e., Fst, Irx3, and Gng13) target
gene promoter-directed reporters. Expression of Sry in trans-
fected cells reduced such reporter activities to the same levels9
SC1.
se in MSC1 cells.
SRY and PARP1 exacerbation (D) on respective targets.
e, showing their upregulation by WNT/b-catenin signaling and suppression by
vation of SRY ovarian targets.
he Sertoli cell-Sertoli junction signaling.
er of Pvrl2, but only slightly by that of Cldn12 and none at all by that of Pvrl1.
ads, respectively. Error bars represent SDs derived from three independent
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as those without b-catenin transactivation (Figure 2E). Our ex-
periments showed that SRY could antagonize the WNT/b-cate-
nin transcriptional activities of ovarian-differentiating genes in a
granulosa cell line.
Various studies indicated that ectopic expression of Sox9, in
the absence of Sry, could induce M sex differentiation (Bishop
et al., 2000; Qin et al., 2004; Vidal et al., 2001), suggesting
that SOX9 could assume SRY functions, including repressing
of WNT/b-catenin activation of ovarian-differentiating genes. To
evaluate such a possibility, similar transfection assays were con-
ducted with a mouse Sox9 construct. Our results showed that
indeed SOX9 suppressed the b-catenin-mediated transactiva-
tion of the same reporters, except that from Bmp2 gene (Fig-
ure 2F), suggesting that SOX9 is capable of interfering the WNT/
b-catenin signaling and repressing the ovarian-differentiating
genes, when it is ectopically expressed during sex determination.
SRY and SOX9 Upregulate the Expression
of Endogenous Testis-Differentiating Genes
in Mouse Sertoli Cells
The effects of ectopically expressed SRY or SOX9 in the Sertoli
cells were examined using a transient transfection strategy.
A Sry or Sox9 transgene was coexpressed with the GFP in
MSC1 cells. Positive cells were purified by preparative flow
cytometry using GFP as a biomarker and analyzed by quantita-
tive RT-PCR (qRT-PCR). The results showed that the Sry and
Sox9 transgenes were expressed at high levels in the corre-
sponding transfected MSC1 cells (Figure 3A). As a target gene
for SRY, the endogenous Sox9 gene was upregulated in Sertoli
cells transiently expressing SRY (Figure 3B). Similarly, expres-
sion levels of known SOX9 targets, Amh and Vanin1, in SOX9-
expressing MSC1 cells increased significantly over the vector-
transfected control (Figure 3C). This initial analysis suggested
that expression of SRY and SOX9 could have significant effects
on the respective endogenous target genes. Using various gene-
specific primers (Table S3), we had examined the expression
of 30 target genes for SRY and SOX9 in the transient transfected
Sertoli cells. Our results showed that approximately two-thirds
of endogenous target genes were stimulated to various levels
in Sry- or Sox9-transfected cells (Figure 3D).
SRY and SOX9 Targets Serve Important Roles in Testis
Cord Formation
To decipher the probable functions and pathways regulated by
SRY and SOX9 during testis development, we had analyzedFigure 3. Effects of Sry and Sox9 Transgene on Gene Expression of Se
(A) Detection of high-level expression of the transfected Sry and Sox9 genes in M
(B) Upregulation of endogenous Sox9 gene in MSC1 cells by a Sry transgene.
(C) Upregulation of two known SOX9 targets, i.e., Amh and Vanin1, in SOX9-exr
(D) Differential upregulation of selected endogenous SRY and SOX9 targets in re
(E) Upregulation of endogenous genes belonging to the Sertoli cell-Sertoli cell junc
to Hprt control.
(F and G) Expression levels (heatmap) of (F) SRY targets and (G) SOX9 targets in th
gonads at E11.5, E12.5, and E13.5 stages. A subset of genes was preferentially
at the E11.5–E13.5 stages (left columns). Both M and F supporting cells at the
supporting cells showed minimal changes toward the E12.5 and E13.5 stages (r
See Table S4 for phenotypes associated with dysfunctions in sex determination
independent experiments.the respective targets with a knowledge base Gene Ontology
analysis system (Ingenuity Pathway Analysis [IPA]). We surmise
that upregulated genes inM supporting cells could serve positive
functions in testicular differentiation; hence, we had also
analyzed SRY and SOX9 targets upregulated in M as compared
to F supporting cells (i.e., M versus F at E11.5, E12.5, and E13.5
stages) and among theM supporting cells at three early stages of
gonadal differentiation (Jameson et al., 2012).
Using the entire target sets for SRY and SOX9, IPA showed
that they were significantly enriched in similar biological pro-
cesses pertaining to cellular growth and proliferation and organ
and embryo development. Notably, the Sertoli cell-Sertoli cell
junction signaling ranked second among the 587 canonical
pathways in the IPA database for the SRY target genes and,
to a lesser extent, those of SOX9 (Table 1). Significantly, this
signaling pathway was the top canonical pathway among the
SRY targets upregulated in M supporting cells at all three
gonadal developmental stages, and between M supporting cells
of E12.5/E13.5 versus E11.5 stage, and again ranked similarly
prominent among the upregulated SOX9 targets. Importantly,
other epithelial adherens, tight junction, and actin cytoskeleton
signalings were also among the top canonical pathways with
the SRY and SOX9 targets (Table 1).
The Sertoli cell-Sertoli cell junction signaling pathway was
initially established for Sertoli cell-Sertoli cell junction formation
in the postnatal and adult testis and is important for the develop-
ment of the blood-testis barrier (BTB) of the seminiferous
tubules. The BTB consists of tight junctions and adherens junc-
tions between Sertoli cells, which are dynamically remodeled
allowing the spermatogenic cells to migrate across the base of
the seminiferous epithelium to the lumen during their maturation
(Cheng andMruk, 2012). The identifications of Sertoli cell-Sertoli
cell junction signaling, actin cytoskeleton signaling, and tight
junction signaling as top canonical pathways among the SRY
and SOX9 targets, especially those upregulated in early Sertoli
cells, suggest that they are important in regulating cell adhesion,
tight junction dynamics, and actin cytoskeletal anchoring in
early testis cord formation and tubulogenesis in the M gonad
(Cool et al., 2012).
Quantitative PCR analysis confirmed the SRY and SOX9
binding to 90% of targets involved in the Sertoli cell-Sertoli
cell junction signaling, similar to those previously studied (Fig-
ures S2D and S2G). Furthermore, promoters of selected target
genes were capable of being activated by a cotransfected
Sry or Sox9 transgene in a reporter assay system (Figure 2G).lected Endogenous Targets in MSC1 Cells
SC1 cells by qRT-PCR.
essing MSC1 cells.
spectively transfected MSC1 cells.
tion signaling pathway in MSC1 cells by Sry and Sox9 transgene, as compared
e Sertoli cell-Sertoli cell junction signaling in M and F supporting cells of mouse
upregulated among the SRY and SOX9 targets (boxed) in M supporting cells
E11.5 stage showed similar, but distinct, expression patterns (middle). The F
ight). E11.5M1 represents E11.5 stage male supporting cells sample 1.
of selected SRY/SOX9 targets. Error bars represent SDs derived from three
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Table 1. Sertoli Cell-Sertoli Cell Junction Signaling and Other
Epithelial Adherens, Tight Junction, and Actin Cytoskeleton
Signaling Pathways among the SRY and SOX9 Targets
Rank Ingenuity Canonical Pathwaysa p Value Ratio
SRY Targets (total targets in E11.5 supporting cells)
2 Sertoli cell-Sertoli
cell junction signaling
2.04 3 106 2.63 3 101
6 Actin cytoskeleton
signaling
1.32 3 105 2.32 3 101
11 Tight junction signaling 8.13 3 105 2.53 3 101
SRY Targets Upregulated in M at E11.5
1 Sertoli cell-Sertoli cell
junction signaling
3.02 3 105 3.76 3 102
2 Remodeling of epithelial
adherens junctions
3.63 3 104 5.97 3 102
5 Actin cytoskeleton
signaling
7.41 3 104 2.58 3 102
6 Epithelial adherens
junction signaling
8.51 3 104 3.45 3 102
8 Germ cell-Sertoli cell
junction signaling
1.12 3 103 3.16 3 102
SRY Targets Upregulated in M at E12.5
1 Sertoli cell-Sertoli
cell junction signaling
2.19 3 103 4.3 3 102
3 Actin cytoskeleton
signaling
6.92 3 103 3.43 3 102
6 Epithelial adherens
junction signaling
1.17 3 102 4.14 3 102
SRY Targets Upregulated in M at E13.5
1 Sertoli cell-Sertoli
cell junction signaling
6.31 3 104 4.30 3 102
3 Epithelial adherens
junction signaling
4.79 3 103 4.14 3 102
4 Remodeling of epithelial
adherens junctions
5.75 3 103 5.97 3 102
5 Germ cell-Sertoli cell
junction signaling
6.61 3 103 3.80 3 102
7 Actin cytoskeleton
signaling
8.12 3 103 3.00 3 102
SRY Targets Upregulated in E12.5 versus E11.5 M
1 Sertoli cell-Sertoli
cell junction signaling
3.89 3 105 4.84 3 102
3 Germ cell-Sertoli cell
junction signaling
6.17 3 104 4.43 3 102
SRY Targets Upregulated in E13.5 versus E11.5 M
1 Sertoli cell-Sertoli cell
junction signaling
4.37 3 105 4.84 3 102
3 Germ cell-Sertoli cell
junction signaling
6.61 3 104 4.43 3 102
SOX9 Targets (total targets in E12.5 supporting cells)
18 Tight junction signaling 3.02 3 103 1.58 3 101
26 Sertoli cell-Sertoli cell
junction signaling
5.13 3 103 1.453 101
Table 1. Continued
Rank Ingenuity Canonical Pathwaysa p Value Ratio
SOX9 Targets Upregulated in M at E11.5
3 Integrin signaling 3.02 3 103 3.37 3 102
13 Paxillin signaling 1.66 3 102 3.57 3 102
14 Germ cell-Sertoli cell
junction signaling
1.74 3 102 3.14 3 102
SOX9 Targets Upregulated in M at E12.5
3 Tight junction signaling 1.70 3 103 4.43 3 102
4 Integrin signaling 1.74 3 103 3.85 3 102
9 Sertoli cell-Sertoli
cell junction signaling
3.80 3 103 3.74 3 102
SOX9 Targets Upregulated in M E13.5
2 Integrin signaling 1.32 3 103 3.85 3 102
3 Tight junction signaling 1.32 3 103 4.43 3 102
7 Sertoli cell-Sertoli
cell junction signaling
3.02 3 103 3.74 3 102
SOX9 Targets Upregulated in E12.5 versus E11.5 M
2 Sertoli cell-Sertoli
cell junction signaling
5.37 3 103 2.69 3 102
6 Tight junction signaling 1.66 3 102 2.53 3 102
10 Integrin signaling 3.71 3 102 1.93 3 102
13 Actin cytoskeleton
signaling
4.79 3 102 1.72 3 102
SOX9 Targets Upregulated in E13.5 versus E11.5 M
1 Sertoli cell-Sertoli
cell junction signaling
6.03 3 103 2.69 3 102
4 Tight junction signaling 1.82 3 102 2.53 3 102
aIPA was performed from April 27 to April 30, 2013.
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clusion of a cotransfected Sf1 transgene could greatly stimulate
the expression of some reporters directed by the respective
target gene promoters (Figure 2H). Selected endogenous SRY
and/or SOX9 targets were stimulated in MSC1 cells transiently
transfected with either a Sry or a Sox9 transgene (Figure 3E).
Collectively, these studies confirmed the bindings and regula-
tion/coregulation of the target genes of this canonical pathway
by SRY and/or SOX9, similar to those previously observed (Fig-
ures 2 and 3).
Because the Sertoli cell-Sertoli cell junction signaling was
initially established in adult testis pertaining to the establishment
and physiology of the BTB, we postulated that perhaps only a
subset of genes involved in this canonical pathway could be
important for testis cord formation in the embryonic testis, in
which spermatogenesis was absent. To explore this possibility,
we had used the hierarchical clustering analysis on the SRY
and SOX9 targets within this signaling pathway with respect to
the expression patterns in the supporting cells at various stages
of sex differentiation in the embryonic gonads. Our results
showed that subsets of the respective targets were preferentially
upregulated in the early M supporting cells, particularly those at
E12.5 and E13.5 testes (Figures 3F and 3G; gene lists in Table
S5). Significantly, based on the expression patterns of the
respective targets, the M and F supporting cells at E12.5 and
E13.5 stages were clustered at opposite sides, whereas those
for E11.5 stage were positioned in themiddle of the dendrogram.
These findings suggest that the expression patterns of both M
and F supporting cells at the early stage, i.e., E11.5, were similar,
but distinguishable. The M supporting cells took on a specific
expression pattern toward later stages, i.e., E12.5 and E13.5,
with the formation of testis cord, a process in which certain
SRY and SOX9 targets were highly expressed and presumably
exerted a positive function(s) (Figures 3F and 3G, boxed),
whereas the F supporting cells showed less dramatic changes
in their expression patterns from E11.5 to E13.5 stages. These
expression patterns seem to parallel the morphological differen-
tiation between M and F gonads at the respective stages, in
which the M gonad shows profound changes with the testis
cord formation, whereas the F gonad shows only slight pheno-
typic changes in its vasculature (Cool et al., 2012).
Because the SRY targets were identified at the E11.5 stage,
whereas their differential expressions were noticeable at this
stage but only became prevalent at the E12.5 and later stages,
SRY must exert its regulatory functions at the E11.5 stage
when its expression was at the peak. Currently, the exact regu-
latory mechanisms for such SRY actions are uncertain. SRY
could play an initial and crucial role(s) in activating or repressing
the respective target genes, whose regulations are then taken
over by collaborating transcription activators or repressors at
the later stages. One prime example of such a gene regulatory
mechanism is the Sox9 gene, which is initially activated collabo-
ratively by SRY and SF1 and subsequently by SF1 and its own
product beyond the active period of SRY. Alternatively, SRY
could recruit chromatin regulators, such as the KAP1-HP1
gene-silencing complex and the chromatin modulator PARP1,
and remodel the chromatin landscapes and accessibility to sub-
sequent transcriptional regulators on its target genes beyond its
own expression in the supporting cells. Nevertheless, our data
support the notion that SRY plays a pivotal role in the initiation
of the vasculature development of embryonic testis, and SOX9
assumes such functions at later stages of the differentiation.
DISCUSSION
SRY Plays Key Roles in Early Events in M Sex
Determination
The Y-located Sry gene serves the indispensable function in M
sex determination, initiated by its activation in supporting cells
of E10.5 gonad and followed by cascades of molecular and
cellular events in early stages (Svingen and Koopman, 2013).
At present, the exact mechanisms by which Sry, Sox9, and other
sex-determining genes mediate the early cellular events are un-
certain. A current hypothesis suggests that SRY primarily
switches on Sox9, the presumedmaster facilitator in testis differ-
entiation (Sekido and Lovell-Badge, 2009). The present study
challenges this paradigm and has provided evidence supporting
the notion that SRY regulates a wide spectrum of targets,
involved in early events in testis differentiation, some of which
could precede the normal Sox9 activation. These early cellular
events include Sertoli cell fate determination, inhibition of ovarian
development, Sertoli cell proliferation and recruitment, arrest ofmeiosis in germ cells and definition of their M lineage, and even-
tual formation of the testis cord, encapsulating the germ cells
(Cool et al., 2012; Svingen and Koopman, 2013). At present,
the exact order of their occurrence is uncertain; SRY could exert
its regulatory actions in simultaneous and/or overlapping man-
ners. We surmise that the initial Sry activation and its subsequent
actions in the supporting cells determine the fate of these cells
to Sertoli cell lineage. SRY binds and regulates Ptgds, whose
product catalyzes the conversion of prostaglandin H2 to prosta-
glandin D2, critical for recruitment of supporting cells into Sertoli
cells (Wilhelm et al., 2005). Fgf9 and Gdnf are involved in Sertoli
cell proliferation (Colvin et al., 2001) and M germ stem cell niche
development (Oatley and Brinster, 2008), respectively. SRY, but
not SOX9, binds in vivo to the promoters of various ovarian-
differentiating genes and suppresses their activation by WNT/
b-catenin signaling. SRY activates Cyp26b1, which encodes
an enzyme degrading retinoid acid (RA), thereby arresting the
RA-induced meiosis and maintaining the germ cells in the M
lineage (Bowles et al., 2006). Other notable SRY targets, such
as Wnt5a and Dhh, are respectively involved in primordial germ
cell migration and testis differentiation (Chawengsaksophak
et al., 2012), and peritubular cell development, seminiferous
tubule formation, and Leydig cell differentiation (Clark et al.,
2000; Yao et al., 2002). Gene inactivation or mutations of other
SRY targets result in abnormalities in sex determination and
differentiation (Table S4). Significantly, Gene Ontology analysis
identified many of the SRY targets, encoding (1) various cell
adhesion molecules, such as cadherins, claudins, and integrins,
and (2) cytoskeletal proteins, such as actins, and (3) signaling
molecules, such as platelet-derived growth factor b (Pdgfb)
and its receptor (Pdgfrb), and (4) MAP kinases, which are impor-
tant in the Sertoli cell-Sertoli cell junction signaling, and cell-cell
adherens and tight junction, and actin cytoskeletal signaling
pathways. Because Sertoli cell-Sertoli cell junction signaling
and adhesion are critical in testis cord formation (Cool et al.,
2012), these SRY targets must serve important functions in the
process(es).
SRY and SOX9 Targets Share Significant Functional
Roles in Testis Differentiation
SRY and SOX9 bind to the same promoter regions of a large
number of common targets in the supporting cells of M gonads.
Among the notable ones, Ptgds, Dhh, Cyp26b1, Pdgfb, Pdgfrb,
and others play key roles in early developmental and cellular
events in testis differentiation, as discussed above. Because
the targets were identified with independent biological replicates
at E11.5 for SRY and E12.5 for SOX9, respectively, such similar-
ities in binding patterns suggest that SOX9 could bind to the
same cis elements and assume the gene regulatory functions
of SRY on their common targets. This postulation is supported
by our data showing that SRY and SOX9 were capable of (1)
regulating each other’s target genes; (2) interacting with the
same coactivators, e.g., SF1, in transactivating respective target
genes; and (3) interfering with theWNT/b-catenin transactivation
of ovarian-differentiating genes in an in vitro and transient
transfection reporter system. We reasoned that the respective
transcription factors were expressed at high levels in such
in vitro assays, thereby increasing their ability in binding to likelyCell Reports 8, 723–733, August 7, 2014 ª2014 The Authors 731
conserved cis elements and/or coregulators and regulate the
expression of the respective promoter-directed reporter or
endogenous target genes in Sertoli cells. Indeed, under diseased
or transgenic conditions, a constitutively active Sox9 could
perform certain functions of SRY in testis differentiation without
a functional Sry gene in the developing gonads (Bishop et al.,
2000; Qin et al., 2004; Vidal et al., 2001). Importantly, SOX9
also regulates a distinct set of unique target genes and exerts
its own gene regulatory program in testis differentiation. Muta-
tion and gene inactivation of the SOX9/Sox9 gene result in XY
partial or complete sex reversal in both patients and transgenic
mice (Chaboissier et al., 2004; Foster, 1996), confirming SOX9
being critical for the continuation of testis differentiation, past
SRY actions. Hence, our study shows that under normal condi-
tions, SRY regulates a variety of genes, which determine the
fate of the Sertoli cells, define the germ cells in the M lineage,
promote Sertoli cell proliferation and recruitment, and induce
the newly differentiated Sertoli cells to form tight and adherens
junctions, important for testis cord formation. Once accom-
plished, it passes on these functions to Sox9, which also acti-
vates its own gene regulatory program and continues the testis
differentiation.
AlthoughSry plays a cardinal role in activating theM sex deter-
mination and early events in testis differentiation, the develop-
mental pathway is complex and likely involved the actions of
Sox9 and other sex-determining genes essential in differentia-
tion of a functional testis (Svingen and Koopman, 2013). As
discussed, SRY likely requires interaction(s) with cofactors,
such as SF1 and SP1, for its gene regulatory functions (Sekido
and Lovell-Badge, 2008; Wu et al., 2009). Significantly, it also in-
teracts with various chromatin modulators, such as PARP1 and
KRAB-O-KAP1-HP1 gene-silencing complex (Li et al., 2006; Oh
et al., 2005), capable of epigenetically remodeling chromatin
landscape of its target genes into ‘‘open’’ or ‘‘close’’ domains
(Oh and Lau, 2006), critical for the accessibility of transcription
factors controlling their expression beyond SRY actions. At pre-
sent, the exact mechanisms responsible for SRY and SOX9
regulation or chromatinmodification of their common and unique
targets are uncertain because the full spectrum of their inter-
active partners is still incomplete. The availability of the present
data sets on SRY and SOX9 targets in the mouse embryonic
gonads at the time of sex determination has provided significant
opportunities for detailed investigations on the specific con-
tributions of these transcription factors and their targets in
mammalian sex determination and differentiation.EXPERIMENTAL PROCEDURES
Single cells were isolated from E11.5 and E12.5 M gonads (Li et al., 2012;
Taketo et al., 2005) and processed for ChIP (Cai et al., 2006). Microarray
hybridization was performed by the Custom Array Service at NimbleGen
Systems, using the 385K RefSeq Promoter Array of the mouse MM8 genome.
All ChIP-Chip experiments were performed in biological replicates. Significant
binding peaks were identified by theMpeak program, version 2.0 (Zheng et al.,
2013). The ChIP-Chip signals and differential gene expression patterns (at
log2 scale) betweenM versus F and changes in expression levels in supporting
cells at different stages of mouse gonadal development (Jameson et al., 2012)
were visualized with the Genome Browser (Karolchik et al., 2011). The
WIG files containing these results are provided in Folder S1. They can732 Cell Reports 8, 723–733, August 7, 2014 ª2014 The Authorsalso be downloaded directly from http://labs.medicine.ucsf.edu/chrislau/
DataSoftware.html. Gene Ontology analyses were performed with the knowl-
edge base IPA (http://www.ingenuity.com) using the Core Analysis module
and the human, rat, and mouse reference set with 587 canonical pathways.
Quantitative PCR was used to confirm SRY or SOX9 bindings on selected
targets (Table S3). Promoters of selected SRY or SOX9 targets were inserted
in front of a luciferase reporter and analyzed in the Sertoli cell line, MSC1, or the
granulosa cell line, KK1 (Li et al., 2006; Oh et al., 2005). To determine the
effects of SRY or SOX9 on endogenous target genes in Sertoli cells, mouse
Sry or Sox9 was transiently transfected in MSC1 cells and analyzed with
qRT-PCR (Table S3).
See Supplemental Experimental Procedures for more details and references
in Supplemental Information.SUPPLEMENTAL INFORMATION
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